ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 393

$818K Total Retail Price of All Prescriptions

Rank: 11 out of 393

1,338 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,338 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 1,338 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 20,383 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,906 1,660 1 1
LISINOPRIL 1,442 1,248 2 2
OMEPRAZOLE 1,131 1,012 3 6
HYDROCODONE-ACETAMINOPHEN 1,116 820 S3 4 5
AMLODIPINE BESYLATE 1,088 950 5 4
LEVOTHYROXINE SODIUM 800 669 6 3
LOVASTATIN 565 516 7 14
FUROSEMIDE 517 432 8 8
METFORMIN HCL 508 408 9 7
ALENDRONATE SODIUM 503 492 10 16
METOPROLOL TARTRATE 483 457 11 9
ATENOLOL 475 437 12 13
ZOLPIDEM TARTRATE 459 367 13 11
HYDROCHLOROTHIAZIDE 397 355 14 10
METOPROLOL SUCCINATE 380 321 15 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 343 300 16 24
LOSARTAN POTASSIUM 341 311 17 12
POTASSIUM CHLORIDE 337 288 18 20
WARFARIN SODIUM 310 262 19 17
VENTOLIN HFA 272 228 20 42
CLOPIDOGREL 257 223 21 33
CARVEDILOL 255 240 22 21
SERTRALINE HCL 241 196 23 28
GABAPENTIN 237 147 24 15
GLIMEPIRIDE 226 176 25 39
RANITIDINE HCL 226 211 25 29
PRAVASTATIN SODIUM 203 175 27 18
PLAVIX 195 173 28 51
SPIRIVA 192 173 29 41
CITALOPRAM HBR 190 165 30 23
GLYBURIDE 168 144 R 31 46
TERAZOSIN HCL 164 131 32 38
DONEPEZIL HCL 155 155 33 34
CLONIDINE HCL 150 111 34 50
METFORMIN HCL ER 149 106 35 63
TRIAMTERENE-HCTZ 147 143 36 49
ATORVASTATIN CALCIUM 146 120 37 19
FLUTICASONE PROPIONATE 146 106 37 27
NIFEDIPINE ER 143 139 39 91
IBUPROFEN 139 74 40 55
HYDRALAZINE HCL 134 132 41 64
TRAMADOL HCL 130 97 42 30
OXYCODONE-ACETAMINOPHEN 126 99 S2 43 71
ISOSORBIDE MONONITRATE ER 120 110 44 67
ALLOPURINOL 120 120 44 26
BISOPROLOL FUMARATE 117 116 46 162
GLYBURIDE-METFORMIN HCL 117 83 R 46 125
BENAZEPRIL HCL 114 95 48 40
GLIPIZIDE 114 102 48 32
MORPHINE SULFATE ER 109 36 S2 50 48
OXYBUTYNIN CHLORIDE 108 100 51 90
OXYCODONE HCL 100 49 S2 52 36
CARISOPRODOL 97 60 R 53 45
LANTUS SOLOSTAR 96 69 54 74
CIPROFLOXACIN HCL 94 84 55 57
PEN NEEDLE 91 55 56 81
KLOR-CON 10 91 80 56 113
DICLOFENAC SODIUM 82 68 58 155
PAROXETINE HCL 80 69 59 61
NAMENDA 77 77 60 59
DIGOXIN 76 76 61 66
DILTIAZEM ER 72 61 62 107
FAMOTIDINE 71 34 63 70
CYCLOBENZAPRINE HCL 70 28 R 64 109
SYMBICORT 68 58 65 96
QVAR 68 65 65 101
LOSARTAN-HYDROCHLOROTHIAZIDE 67 65 67 31
TRAZODONE HCL 66 59 68 47
LANTUS 65 42 69 73
ROPINIROLE HCL 64 50 70 121
MELOXICAM 61 34 71 58
FLUOXETINE HCL 61 46 71 37
NIFEDICAL XL 60 57 73 277
OXYCODONE HCL-ACETAMINOPHEN 59 39 S2 74 54
SUMATRIPTAN SUCCINATE 57 24 75 227
NAPROXEN 56 29 76 85
ATENOLOL-CHLORTHALIDONE 56 51 76 201
FINASTERIDE 55 53 78 60
FLUOCINONIDE 54 54 79 224
BENICAR 54 54 79 118
MECLIZINE HCL 53 42 81 163
INSULIN SYRINGE 53 42 81 110
NIFEDIAC CC 52 50 83 203
VERAPAMIL ER 52 39 83 86
AMITRIPTYLINE HCL 50 32 R 85 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.